arsenic trioxide has been researched along with cholecalciferol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dölken, G; Greinacher, A; Jedlitschky, G; Kiefer, T; Köck, K; Kroemer, HK; Niessen, J; Oevermann, L; Ritter, CA; Scheitz, J; Siegmund, W; Starke, K; Zygmunt, M | 1 |
| Asghari, F; Mozdarani, H | 1 |
2 other study(ies) available for arsenic trioxide and cholecalciferol
| Article | Year |
|---|---|
Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs.
Topics: Antigens, CD34; Arsenic Trioxide; Arsenicals; Base Sequence; Blotting, Western; Cell Differentiation; Cholecalciferol; DNA Primers; Flow Cytometry; Hematopoietic Stem Cells; Humans; Microscopy, Fluorescence; Multidrug Resistance-Associated Proteins; Oxides; Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate | 2009 |
Potent reducing effects of vitamin D3 on the frequency of apoptosis induced by arsenic trioxide in NB4 cell line.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Cholecalciferol; Dose-Response Relationship, Drug; Humans; Leukemia, Promyelocytic, Acute; Oxides | 2010 |